These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2079251)

  • 1. [Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
    Schmid KW; Hittmair A; Tötsch M; Müller E; Zaimet A; Tauscher T; Dünser M; Ofner D
    Gynakol Rundsch; 1990; 30 Suppl 1():150-1. PubMed ID: 2079251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 4. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
    Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
    Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunocytochemical detection of the estrogen receptor and lectin binding sites in tumor cell colonies growing in vitro].
    Werner A; Bellmann O; Vogel J; Kurbacher C; Nagel W; Diedrich K; Krebs D
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):299-304. PubMed ID: 3294084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors.
    Westhof G; Bader W; Greiner-Mai E; Hatzmann W
    Tumour Biol; 2000; 21(3):123-34. PubMed ID: 10754462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leiomyomatosis peritonealis disseminata. Immunohistochemical case analysis with determination of estrogen and progesterone receptors].
    Düe W; Pickartz H
    Pathologe; 1987 Sep; 8(5):291-7. PubMed ID: 3313377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
    Fleige B; Pickartz H; Stein H
    Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
    Pickartz H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
    Kasch R; Meissner J; Haack D; Neumann S
    Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gynecologic cancers: preventive examinations and their limits. An analysis of the current staging and percentage distribution based on 2,612 cancers of the 1 January 1983 to 25 November 1985 cumulative statistics of the Society of Swiss Gynecologic Clinics].
    Hochuli E; Benz J; Litschgi M; Marti WK
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):278-83. PubMed ID: 3721158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
    Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
    Scharl A; Vierbuchen M; Würz H
    Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gynaecological and breast cancers at the Dakar Cancer Institute].
    Dem A; Traoré B; Dieng MM; Diop PS; Ouajdi T; Lalami MT; Diop M; Dangou JM; Touré P
    Sante; 2008; 18(1):25-9. PubMed ID: 18684687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.